{
  "id": "CD015003.PUB2",
  "draft": "# Can colchicine (an anti-inflammatory medicine) help prevent heart attacks, strokes, and other cardiovascular events in people who have not had any of these problems before?\n\n**Key Messages**\n- Colchicine (an anti-inflammatory medicine) may help reduce the risk of death from any cause (all-cause mortality) in people who have not had any cardiovascular problems before, but the evidence is not strong enough to be certain, and it may increase the risk of diarrhoea (a condition characterized by loose, watery stools).\n- The current evidence does not clearly show whether colchicine can prevent heart attacks, strokes, or other cardiovascular events in people without a history of these problems, highlighting the need for more research to understand its effects.\n- Future studies should investigate the long-term effects of colchicine and its potential benefits and harms in preventing cardiovascular events, as the current evidence is limited by biases and inaccuracies in the included studies, making it difficult to draw firm conclusions.\n\n**Introduction**\n### What is atherosclerotic cardiovascular disease and why is it a problem?\nAtherosclerotic cardiovascular disease (ACVD) is a condition where the arteries become clogged with fatty substances, leading to chronic inflammation and potentially life-threatening complications. It is a major cause of mortality and morbidity worldwide, resulting in significant healthcare burdens and impacting the quality of life for millions of people. Common treatments for ACVD often focus on managing symptoms and reducing risk factors, but there is a need for effective preventive measures.\n### What is colchicine and how might it help with ACVD prevention?\nColchicine is an inexpensive drug with anti-inflammatory properties that has been used for centuries. Its potential role in preventing ACVD is of interest due to its ability to reduce inflammation, a key factor in the development of the disease. However, the effectiveness of colchicine in preventing cardiovascular events in the general population remains unknown, highlighting the need for rigorous research to determine its clinical benefits and harms.\n### What did the review authors want to find out?\nThe review authors aimed to assess the clinical benefits and harms of using colchicine for the primary prevention of cardiovascular events in the general population. They compared colchicine to placebo, immunomodulating medications, or usual care to determine its effectiveness in reducing the risk of cardiovascular outcomes such as all-cause mortality, non-fatal myocardial infarction, stroke, and adverse events.\n\n**Methods**\n### Methods\nWe searched for studies comparing colchicine to other treatments for preventing cardiovascular events, summarized their results, and rated our confidence in the evidence.\n\n**Results**\n### What did we find?\nWe found 15 studies that involved 1721 people who were randomised and 1412 participants were analysed. The studies were conducted with follow-up periods ranging from 4 to 728 weeks. The intervention was oral colchicine compared with placebo, immunomodulating drugs, or usual care or no treatment. Most of the included trials focused on liver disease, rather than the general population. The population characteristics, such as age and gender, were not reported in the abstract. The study settings, including countries, were also not specified. The types of interventions and comparisons were colchicine versus placebo, immunomodulating drugs, or usual care. No information on study funding sources was provided. Colchicine may reduce the risk of all-cause mortality, but we are very uncertain about the results. It may make little to no difference to the risk of non-fatal myocardial infarction, but we are very uncertain about the results. Colchicine may increase the risk of diarrhoea. For every 100 people taking colchicine, 10 may experience diarrhoea, compared to 3 of 100 people not taking colchicine.\n\n**Limitations**\nThe evidence is limited because the studies were very small, participants may have been aware of their assigned treatment (risk of bias due to lack of blinding), and the evidence does not cover all relevant populations, interventions, comparators, or outcomes of interest.\n\n**Currency**\nThe evidence is up to date to May 2023.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 685,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 32,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 21.40625,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 21,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 21.0 to <13.0 (median)"
        },
        "active_voice": {
          "value": 51,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 33,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 28,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 28.0 to <13.0 (median)"
        },
        "nouns": {
          "value": 183,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 183.0 to <116.0 (median)"
        },
        "flesch_reading_ease": {
          "value": 40.11437157846717,
          "rating": "P25",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 12.982087135036497,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 13.325066605839417,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 12.843854014598541,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 18.31432481751825,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 54.690921532846716,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 7.125,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 15.68857754044952,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 15.7 to <12.1 (median)"
        },
        "dale_chall_readability": {
          "value": 7.562158759124087,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 282,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 282.0 to <160.0 (median)"
        },
        "complex_words": {
          "value": 167,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 167.0 to <84.0 (median)"
        },
        "long_words": {
          "value": 228,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 228.0 to <122.0 (median)"
        }
      },
      "word_count_status": {
        "word_count": 685,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 685 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 1,
        "P50_count": 4,
        "P75_count": 6,
        "P90_count": 2,
        "P10_count": 0,
        "BEYOND_P90_count": 5,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 5.555555555555555,
        "P50_percentage": 22.22222222222222,
        "P75_percentage": 33.33333333333333,
        "P90_percentage": 11.11111111111111,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 27.77777777777778,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 38.88888888888889,
        "overall_assessment": "MODERATE CONFORMITY WITH PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "The draft is NOT APPROVED due to several critical issues, including incorrect subheading formatting, factual inaccuracies, and inappropriate content in the Results section. Additionally, there are significant clarity and style issues related to jargon, wordiness, excessive passive voice, and overall vocabulary complexity, which are supported by the linguistic analysis.\n\n**Top 5 Improvements Needed:**\n\n1.  **Improve Subheading Format:**\n    *   **Specific Quote:** \"### Methods\", \"### Limitations\", \"### Currency\"\n    *   **Why problematic:** The `MASTER_STYLE_GUIDE` requires all subheadings to be phrased as questions to enhance readability and engagement for patients. These are declarative statements.\n    *   **Suggested Rewrite:**\n        *   For \"### Methods\": \"### How did we find the evidence?\"\n        *   For \"### Limitations\": \"### What are the limitations of this evidence?\"\n        *   For \"### Currency\": \"### How up to date is this evidence?\"\n\n2.  **Correct Factual Inaccuracy and Remove Inappropriate Content in Results:**\n    *   **Specific Quote:** \"The population characteristics, such as age and gender, were not reported in the abstract. The study settings, including countries, were also not specified. The types of interventions and comparisons were colchicine versus placebo, immunomodulating drugs, or usual care. No information on study funding sources was provided.\"\n    *   **Why problematic:** This section contains statements that are factually inaccurate (e.g., the `ORIGINAL_ABSTRACT` *does* mention \"general population\" and \"adults without pre-existing cardiovascular disease\" as population characteristics). More importantly, statements about what was *not* reported in the abstract (like funding sources) are meta-commentary about the abstract itself, not findings from the studies, and are inappropriate for a patient-facing Plain Language Summary results section. It also redundantly lists comparisons already mentioned.\n    *   **Suggested Rewrite:** Remove these sentences entirely. The preceding sentence, \"Most of the included trials focused on liver disease, rather than the general population,\" already addresses a key point about the study population in a relevant way.\n\n3.  **Simplify Jargon and Wordy Phrases:**\n    *   **Specific Quote:** \"Colchicine (an anti-inflammatory medicine) may help reduce the risk of death from any cause (all-cause mortality) in people who have not had any cardiovascular problems before, but the evidence is not strong enough to be certain, and it may increase the risk of diarrhoea (a condition characterized by loose, watery stools).\" (Key Messages)\n    *   **Why problematic:** \"All-cause mortality\" is jargon, even with a parenthetical explanation. \"A condition characterized by loose, watery stools\" is an overly wordy definition for \"diarrhoea.\" Similarly, \"non-fatal myocardial infarction\" in the Results section is jargon that could be simplified.\n    *   **Suggested Rewrite:** \"Colchicine (an anti-inflammatory medicine) may help reduce the risk of death from any cause in people who have not had any heart or blood vessel problems before, but the evidence is not strong enough to be certain. It may also increase the risk of diarrhoea.\" (For the Key Message). For the Results section: \"It may make little to no difference to the risk of non-fatal heart attacks, but we are very uncertain about the results.\"\n\n4.  **Reduce Passive Voice and Noun-Heavy Constructions:**\n    *   **Specific Quote:** \"We found 15 studies that involved 1721 people who were randomised and 1412 participants were analysed.\" (Results)\n    *   **Why problematic:** This sentence uses passive voice (\"were randomised\", \"were analysed\") and is somewhat noun-heavy, making it less direct and harder to read. The linguistic analysis shows a high number of passive voice constructions and nominalizations, indicating a pervasive issue.\n    *   **Suggested Rewrite:** \"We found 15 studies. Researchers randomly assigned 1721 people to groups, and we analyzed data from 1412 participants.\" (This also breaks a slightly long sentence and uses active voice).\n\n5.  **Address Overall Vocabulary Complexity:**\n    *   **Specific Quote:** \"Atherosclerotic cardiovascular disease (ACVD) is a condition where the arteries become clogged with fatty substances, leading to chronic inflammation and potentially life-threatening complications.\" (Introduction)\n    *   **Why problematic:** While ACVD is defined, the sentence is long and contains several complex terms. The high `smog_index`, `complex_words_dc`, `complex_words`, and `long_words` metrics indicate a pervasive issue with vocabulary complexity throughout the draft, making it difficult for the target audience to understand.\n    *   **Suggested Rewrite:** \"Atherosclerotic cardiovascular disease (ACVD) is when fatty substances clog the arteries. This can cause long-lasting inflammation and serious, even life-threatening, health problems.\" (This is an example; the writer should review the entire text for similar opportunities to simplify vocabulary and sentence structure, and break down long sentences.)",
      "pls_evaluation_summary": "The draft is 685 words, which is within the recommended limit. However, the linguistic analysis reveals moderate conformity with typical PLS patterns, with 7 out of 18 features deviating significantly from typical ranges. Specifically, `passive_voice` (21.00), `nouns` (183.00), `nominalization` (28.00), `smog_index` (15.69), `complex_words_dc` (282.00), `complex_words` (167.00), and `long_words` (228.00) are all considerably higher than typical PLS texts (P90 or BEYOND_P90). This indicates that the text is generally too complex, uses too much passive voice, and is overly noun‑heavy, which will significantly hinder patient understanding and readability."
    }
  ]
}